Shilpa Biologics Dharwad site gets European GMP certification Ruchika Sharma5 May 2025 1:30 PM ISTShilpa Medicare has announced that its Biologics arm, Shilpa Biologics site at Dharwad, Karnataka, has received its European GMP certification for...
Biocon Biologics secures multiple market access agreements in US for Yesintek Ruchika Sharma5 May 2025 12:50 PM ISTYESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
WHO to back use of weight-loss drugs as obesity treatment in adults Ruchika Sharma5 May 2025 11:00 AM ISTLondon: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity in adults for the...
CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study Dr. Divya Colin4 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved AstraZeneca...
Johnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for injection Dr. Divya Colin4 May 2025 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to...
EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients Ruchika Sharma4 May 2025 12:30 PM ISTBerlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma Ruchika Sharma4 May 2025 10:30 AM ISTAstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that...
CDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept Dr. Divya Colin3 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved Dr Reddys...
CDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan Dr. Divya Colin3 May 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has approved the protocol...
Rajasthan govt set to revive Rajasthan Drugs and Pharma Ruchika Sharma3 May 2025 4:46 PM ISTJaipur: The government of Rajasthan is set to revive Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU)...
Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
